Ray Dalio’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-49,578
Closed -$985K 786
2023
Q1
$985K Buy
49,578
+1,897
+4% +$32.8K 0.01% 564
2022
Q4
$649K Sell
47,681
-14,691
-24% -$205K ﹤0.01% 697
2022
Q3
$864K Sell
62,372
-382
-0.6% -$5.67K ﹤0.01% 718
2022
Q2
$901K Buy
62,754
+5,911
+10% +$103K ﹤0.01% 802
2022
Q1
$1.28M Buy
56,843
+13,245
+30% +$257K 0.01% 768
2021
Q4
$819K Buy
43,598
+3,678
+9% +$98.2K ﹤0.01% 607
2021
Q3
$1.31M Sell
39,920
-1,733
-4% -$64.7K 0.01% 480
2021
Q2
$1.78M Buy
+41,653
New +$1.63M 0.01% 510

Other funds holding CSII

Ray Dalio's CSII Position: Q2 2023 in Review

Ray Dalio sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 49,578 shares — an estimated $985K sold.

Ray Dalio first reported a position in CSII in Q2 2021 and held it in 8 quarters. The position peaked at $1.78M in Q2 2021. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

  • Ray Dalio reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
  • Ray Dalio sold 49,578 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $985K.
  • Ray Dalio first reported a position in Cardiovascular Systems, Inc. in Q2 2021 and held it in 8 quarters.
  • Ray Dalio's Cardiovascular Systems, Inc. position peaked at $1.78M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Bridgewater Associates's 13F filing for Q2 2023, filed 11 Aug 2023.